Muhtasim Mannan

Founder @Eranostix

Founder of Eranostix, a startup focussing on introducing molecular diagnostics and therapeutics to mass population emerging markets, and using such a platform of existing and novel tech to establish clinical R&D in these markets. Part of Harvard Innovation Labs as separate venture, pivoted to Eranostix in September 2021 and officially incorporated in March 2022.Offered $1 million in an initial investment offer in November 2021.Part of the Harvard Innovation Labs Venture Program (since September 2020; Eranostix is the result of a pivot from the initial venture, that took place in September 2021). Awarded the Harvard Innovation Labs Spark Grants in Fall 2021, Spring 2022, and Summer 2022.Working towards signing partnerships with the Bangladeshi government, entered formal partnerships with the only tertiary medical university of Bangladesh (BSMMU) and one of the largest NGOs in Bangladesh, as well as with other institutions and clinics